Daniel R. Chevallard, CFO and COO at Viracta Therapeutics, Inc. (VIRX), sold 3,532 shares at $2.72 ($10K) on 2022-11-28, disclosed to the SEC on 2022-11-29.
Open-market sale of $10k VIRX by CFO and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LENZ | BUY | 2024-05-15 | $50K | — | Filing → |
| VIRX | SELL | 2024-02-27 | $2K | — | Filing → |
| VIRX | SELL | 2023-11-28 | $2K | — | Filing → |